What is it? Why is it important?

An intervention is an action or procedure that is carried out and tested. In clinical studies, this could include the:

  • Administration of a new drug
  • Administration of an approved drug in a new indication (e.g. an approved HIV drug is newly tested to treat rheumatic disease)
  • Implementation of a new medical device
  • Testing of a new surgical procedure or technology
  • Use of a new diagnostic test or tool to detect a particular condition
  • Introduction of lifestyle changes (e.g. special diets, workout programs)

 

Apart from the intervention, the SP-INV can decide to include a control group. A control group provides an alternative or reference point to the intervention, such as:

  • A placebo group (e.g. a treatment with no active ingredient)
  • A standard-of-care treatment group (e.g. existing treatment procedures or an approved drug for a given disease)

 

Comparing the intervention with the control group answers the question whether the intervention was effective and safe.

What do I need to do?

As a SP-INV:

  • Define and assess the feasibility of a study design that includes both an intervention and a control group (e.g. ethical concerns, production costs, accessibility of the target-population, product handling)
  • Define the intervention and control group of your study, for example:
    • Intervention group: the administration of the new drug via infusion once a day for 10 days.
    • Control group: the administration of a placebo solution (e.g., a saline solution) via infusion once a day for 10 days.

 

In blinded studies, ensure the placebo, be it a pill, injections, ointment, or some other product, is undistinguishable from the intervention. Aspects to consider include:

  • Outer packaging material
  • Visual properties (e.g. shape, size, colouring)
  • Tactile properties (e.g. density, smoothness, viscosity, feel)
  • Smell, colour, and auditory properties

 

The production of a placebo is costly. Ensure to include it in the study budget.

Where can I get help?

Your local CTU can support you with experienced staff regarding this topic

 

Swiss Law

ClinO – see in particular articles

  • Art. 2b Definition of intervention
  • Art. 2h Definition of placebo

HRA – see in particular article

  • Art. 13 Placebo
Abbreviations
  • CTU – Clinical Trials Unit$
  • SP-INV – Sponsor Investigator
Basic ↦ Statistic Methodology ↦ Research Question ↦ Intervention and Control Group
Study
Basic

Provides some background knowledge and basic definitions

Basic Monitoring
Basic Drug or Device
Concept

Starts with a study idea

Ends after having assessed and evaluated study feasibility

Concept Statistic Methodology
Concept Drug or Device
Development

Starts with confidence that the study is feasible

Ends after having received ethics and regulatory approval

Development Drug or Device
Set-Up

Starts with ethics and regulatory approval

Ends after successful study initiation

Set-Up Ethics and Laws
Set-Up Statistic Methodology
Set-Up Quality and Risk
Set-Up Drug or Device
Conduct

Starts with participant recruitment

Ends after the last participant has completed the last study visit

Conduct Statistic Methodology
Conduct Drug or Device
Completion

Starts with last study visit completed

Ends after study publication and archiving

Completion Drug or Device
Current Path (click to copy): Basic ↦ Statistic Methodology ↦ Research Question ↦ Intervention and Control Group

Please note: the Easy-GCS tool is currently under construction.